ATRenew Inc. RERE
Last close
—
Market cap
—
52-week range
— - —
No price or market cap here: this company files no 10-K, so the only share count SEC publishes for it counts its ordinary shares in its home market, while its US listing is a depositary receipt standing for some number of them. That number is in no filing, so a price multiplied by that count is not this company's value and is not shown. The financial statements below are as filed.
Valuation FY2025 figures against the last close
P/S—
P/E—
P/FCF—
EV/EBITDA—
Dividend yield—
Diluted EPS0.30
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| R&D | $34.9M | — | — | — | — | — |
| SG&A | $39.3M | $42.0M | $37.5M | $33.4M | $68.0M | — |
| Total operating expenses | — | — | — | — | $1.37B | — |
| Operating income | $65.2M | $4.0M | -$24.4M | -$380.4M | -$140.5M | — |
| Interest expense | $863.0K | $2.1M | $994.0K | $894.0K | $2.6M | — |
| Pre-tax income | $65.8M | -$61.0K | -$20.9M | -$373.1M | -$149.7M | — |
| Income tax | $8.1M | $7.8M | $6.0M | $16.2M | $22.6M | — |
| Net income | $48.1M | -$1.1M | -$22.0M | -$357.8M | -$128.1M | — |
| EPS, basic | 0.30 | -0.01 | -0.14 | -2.20 | — | — |
| EPS, diluted | 0.30 | -0.01 | -0.14 | -2.20 | -2.16 | — |
| Shares, diluted (wtd. avg.) | 162.2M | 161.6M | 162.2M | 162.8M | 96.3M | 18.8M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | $219.9M | $269.9M | $278.7M | $247.0M | $212.8M | — |
| Short-term investments | $38.3M | $80.0M | $57.8M | $113.4M | $80.1M | — |
| Receivables | $18.8M | — | — | — | — | — |
| Inventory | $153.6M | $73.3M | $143.3M | $62.8M | $75.1M | — |
| Total current assets | $678.0M | $571.2M | $637.6M | $564.0M | $651.4M | — |
| Property, plant and equipment | $34.2M | $21.4M | $20.9M | $17.2M | $16.3M | — |
| Goodwill | — | — | — | — | $283.0M | — |
| Other intangibles | $1.5M | $7.8M | $38.1M | $79.0M | $168.8M | — |
| Total assets | $853.1M | $697.4M | $773.7M | $732.0M | $1.18B | — |
| Accounts payable | $48.0M | $23.5M | $75.0M | $10.6M | $6.5M | — |
| Short-term debt | $46.2M | $30.8M | $49.3M | $18.0M | $14.9M | — |
| Total current liabilities | $272.1M | $179.1M | $238.2M | $148.2M | $129.4M | — |
| Total liabilities | $282.5M | $191.3M | $250.9M | $169.2M | $169.8M | — |
| Retained earnings | -$1.26B | -$1.26B | -$1.29B | -$1.31B | -$1.03B | — |
| Total equity | $570.6M | $506.2M | $522.7M | $562.8M | $1.01B | — |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$59.3M | $88.1M | $34.4M | $127.8M | -$159.7M | — |
| Depreciation and amortisation | $16.6M | $36.6M | $47.0M | $58.8M | $58.6M | — |
| Stock-based compensation | $7.6M | $22.8M | $18.9M | $25.3M | $71.3M | — |
| Capital expenditure | $20.6M | $8.2M | $12.0M | $8.9M | $11.6M | — |
| Investing cash flow | -$19.5M | -$58.1M | $24.2M | -$74.9M | -$105.2M | — |
| Financing cash flow | -$2.0M | -$42.2M | $9.7M | -$27.0M | $359.3M | — |
| Buybacks | $13.2M | $25.2M | $22.5M | $34.0M | — | — |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0001193125-26-146260.
Plot the figures US dollars
Income statement
Revenue
Cost of revenue
Gross profit
R&D
SG&A
Total operating expenses
Operating income
Interest expense
Pre-tax income
Income tax
Net income
EPS, basic
EPS, diluted
Shares, diluted (wtd. avg.)
- Revenue
- Gross profit
- Net income
| Fiscal year | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Net income | — | -$128.1M | -$357.8M | -$22.0M | -$1.1M | $48.1M |
Others in SIC 5990
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| ULTA | Ulta Beauty, Inc. | $26.70B | 24.4x | 9.7% |
| BBWI | Bath & Body Works, Inc. | $4.22B | 6.7x | -0.2% |
| SBH | Sally Beauty Holdings, Inc. | $1.63B | 9.2x | -0.4% |
| WOOF | Petco Health & Wellness Company, Inc. | $699.8M | 81.7x | -2.5% |
| TITN | Titan Machinery Inc. | $544.1M | — | -10.2% |
| SGU | STAR GROUP, L.P. | $431.5M | — | 1.0% |
| NEGG | Newegg Commerce, Inc. | $203.4M | — | 16.9% |
| FLWS | 1 800 FLOWERS COM INC | $183.2M | — | -8.0% |